Independent Advisor Alliance Adma Biologics, Inc. Transaction History
Independent Advisor Alliance
- $2.95 Billion
- Q1 2025
A detailed history of Independent Advisor Alliance transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Independent Advisor Alliance holds 89,475 shares of ADMA stock, worth $1.63 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
89,475Holding current value
$1.63 Million% of portfolio
0.06%Shares
4 transactions
Others Institutions Holding ADMA
# of Institutions
393Shares Held
190MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$340 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$308 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$235 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$209 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$103 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.59B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...